Kopera H
Acta Psychiatr Belg. 1978 Sep-Oct;78(5):787-97.
The presented data clearly show that mianserin, which is therapeutically equal to other antidepressants, is a drug with a new chemical structure, with a most probably different mechanism of action and with distinct advantages above comparative drugs. Mianserin has not only pronouncedly fewer anticholinergic and central side-effects but: a) apparently has no cardiotoxic effects neither on healthy subjects nor on depressive individuals nor on cardiac patients; b) doses not cause orthostatic hypotension; c) is devoid of adverse drug-drug interactions with coumarin-like anticoagulants, with sympathomimetic amines, with antihypertensive agents and shows but little and short lasting interactions with alcohol.
所呈现的数据清楚地表明,米安色林在治疗效果上与其他抗抑郁药相当,是一种具有新化学结构的药物,其作用机制很可能不同,且相对于对照药物具有明显优势。米安色林不仅抗胆碱能和中枢副作用明显较少,而且:a) 对健康受试者、抑郁症患者和心脏病患者显然均无心脏毒性作用;b) 不会引起体位性低血压;c) 与香豆素类抗凝剂、拟交感胺、抗高血压药物不存在不良药物相互作用,与酒精的相互作用也很小且持续时间短。